AXOVANT GENE THERAPIES LTD's ticker is and the CUSIP is G0750W953. A total of 3 filers reported holding AXOVANT GENE THERAPIES LTD in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $171,000 | +280.0% | 374 | +125.3% | 0.00% | – |
| Q2 2020 | $45,000 | +4.7% | 166 | -8.3% | 0.00% | – |
| Q1 2020 | $43,000 | -72.1% | 181 | -40.5% | 0.00% | – |
| Q4 2019 | $154,000 | -21.4% | 304 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $196,000 | -72.7% | 304 | -73.6% | 0.00% | -50.0% |
| Q2 2019 | $717,000 | – | 1,152 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 3,000 | $8,000 | 0.00% |
| SIMPLEX TRADING, LLC | 166 | $45,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |